These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35152072)

  • 1. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
    Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
    J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Tumor-Specific Disulfiram Chemotherapy by
    Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
    J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
    Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
    ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
    Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
    Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
    Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
    Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
    Rieber M
    Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
    Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
    ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart Tumor Microenvironment-Responsive Nano-Prodrug for Disulfiram Toxification In Situ and the Exploration of Lethal Mechanisms in Cells.
    Zhang Y; Qi G; Qu X; Wang B; Ma K; Jin Y
    Langmuir; 2022 Jan; 38(1):584-592. PubMed ID: 34971310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tumor microenvironment-activated metal-organic framework-based nanoplatform for amplified oxidative stress-induced enhanced chemotherapy.
    Li B; Yao X; Li J; Lu X; Zhang W; Duan W; Tian Y; Li D
    J Biol Chem; 2023 Jan; 299(1):102742. PubMed ID: 36435198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Microenvironment-Responsive Cerium-Enriched Copper Nanozyme with O
    Lin J; Huang C; Wang P; He Y; Luo Q; Liu X; Li Y
    Adv Healthc Mater; 2024 Apr; 13(11):e2303955. PubMed ID: 38271271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor specific in situ synthesis of therapeutic agent for precision cancer therapy.
    Zhou Z; Zhou C; Liu J; Yuan Y; Yao C; Liu M; Deng L; Sun J; Chen Z; Wang L; Wang Z
    J Nanobiotechnology; 2024 Oct; 22(1):612. PubMed ID: 39385273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of a double targeting nanoplatform to elevate ROS generation and DSF anticancer activity.
    Li W; Huang H; Yao S; Zhao Y; Liu M; Liu X; Guo H
    J Mater Chem B; 2024 Jul; 12(29):7143-7152. PubMed ID: 38904428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
    Calderon-Aparicio A; Strasberg-Rieber M; Rieber M
    Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
    Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis.
    Li C; Zhou S; Chen C; Zhu L; Li S; Song Z; Liang J; Tang C; Xu N; Liu T; Liu S
    Colloids Surf B Biointerfaces; 2023 May; 225():113253. PubMed ID: 36934611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intelligent Cu/ZIF-8-based nanodrug delivery system for tumor-specific and synergistic therapy via tumor microenvironment-responsive cascade reaction.
    Wei F; Hou L; Yao Y; Lai Y; Lin T; Zhao S; Tang D
    Mikrochim Acta; 2024 Jul; 191(8):447. PubMed ID: 38963544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
    Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
    Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.